Chahoud et al., 2022 - Google Patents
Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-upChahoud et al., 2022
View HTML- Document ID
- 3170736628245841756
- Author
- Chahoud J
- Zacharias N
- Pham R
- Qiao W
- Guo M
- Lu X
- Alaniz A
- Segarra L
- Martinez-Ferrer M
- Gleber-Netto F
- Pickering C
- Rao P
- Pettaway C
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Simple Summary Penile Squamous Cell Carcinoma (PSCC) is a rare but aggressive cancer and approximately 30–50% of cases are associated with high risk human papillomavirus (HR-HPV). HR-HPV infection has been shown to correlate with expression of protein …
- 241000701806 Human papillomavirus 0 title abstract description 104
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Inamura | Update on immunohistochemistry for the diagnosis of lung cancer | |
Chahoud et al. | Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up | |
Kühn et al. | HPV status as prognostic biomarker in head and neck cancer—which method fits the best for outcome prediction? | |
Wendt et al. | Long-term survival and recurrence in oropharyngeal squamous cell carcinoma in relation to subsites, HPV, and p16-status | |
Hermida-Prado et al. | Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients | |
Sheppard et al. | Lymph node yield and ratio in selective and modified radical neck dissection in head and neck cancer—impact on oncological outcome | |
Idel et al. | EVI1 as a Marker for Lymph Node Metastasis in HNSCC | |
Niu et al. | NR2F6 expression correlates with pelvic lymph node metastasis and poor prognosis in early-stage cervical cancer | |
Van Bockstal et al. | Interobserver agreement of PD-L1/SP142 immunohistochemistry and tumor-infiltrating lymphocytes (TILs) in distant metastases of triple-negative breast cancer: a proof-of-concept study. A report on behalf of the International Immuno-Oncology Biomarker Working Group | |
Cass et al. | Automated quantitative analysis of p53, Cyclin D1, Ki67 and pERK expression in breast carcinoma does not differ from expert pathologist scoring and correlates with clinico-pathological characteristics | |
Ivković et al. | Role of matrix metalloproteinases and their inhibitors in locally invasive papillary thyroid cancer | |
Parosanu et al. | The prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma | |
Ko et al. | Overexpression of LGR-5 as a predictor of poor outcome in patients with hepatocellular carcinoma | |
Tagliabue et al. | Prevalence of central compartment lymph node metastases in papillary thyroid micro-carcinoma: A retrospective evaluation of predictive preoperative features | |
Susini et al. | Immunohistochemical evaluation of FGD3 expression: A new strong prognostic factor in invasive breast cancer | |
Pinheiro et al. | Incidental node metastasis as an independent factor of worse disease-free survival in patients with papillary thyroid carcinoma | |
Pizzimenti et al. | BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category | |
Troiano et al. | Immunohistochemical analysis revealed a correlation between Musashi-2 and Cyclin-D1 expression in patients with oral squamous cells carcinoma | |
Angelico et al. | Evaluation of beta-catenin subcellular localization and water channel protein AQP1 expression as predictive markers of chemo-resistance in ovarian high-grade serous carcinoma: comparative study between preoperative peritoneal biopsies and surgical samples | |
Babiker et al. | Clinicopathologic aspects of squamous cell carcinoma of the uterine cervix: role of PTEN, BCL2 and P53 | |
Kawai et al. | Melanoma inhibitory activity and melanoma inhibitory activity 2 as novel immunohistochemical markers of oral epithelial dysplasia | |
Montes-Mojarro et al. | Multiparametric classification of non-muscle invasive papillary urothelial neoplasms: combining morphological, phenotypical, and molecular features for improved risk stratification | |
Forsare et al. | The prognostic role of intratumoral stromal content in lobular breast cancer | |
Sjöblom et al. | Tumor-associated trypsin inhibitor (TATI) as a biomarker of poor prognosis in oropharyngeal squamous cell carcinoma irrespective of HPV status | |
Muroni et al. | Prognostic impact of membranous/nuclear epidermal growth factor receptor localization in clear cell renal cell carcinoma |